Vergoeding 2015-2019 voor ATC-subgroep C07AB : Selectieve beta-blokkers
- Raming voor de totale Zvw-populatie
| 2015 | 2016 | 2017 | 2018 | 2019 | |
|---|---|---|---|---|---|
| C07AB02 Metoprolol (Selokeen ®) | 13.084.800 | 12.070.400 | 12.069.400 | 12.553.000 | 13.083.500 |
| C07AB03 Atenolol | 1.100.600 | 1.054.000 | 1.036.900 | 1.000.500 | 1.124.900 |
| C07AB04 Acebutolol | 127.050 | 115.160 | 96.200 | 89.503 | 85.102 |
| C07AB07 Bisoprolol (Emcor ®) | 2.136.300 | 2.179.400 | 2.261.500 | 2.373.300 | 2.948.900 |
| C07AB08 Celiprolol (Dilanorm ®) | 350.690 | 360.730 | 355.740 | 315.290 | 272.160 |
| C07AB12 Nebivolol (Nebilet ®) | 1.061.700 | 1.129.500 | 1.055.500 | 1.138.200 | 1.213.000 |
| Totaal | 17.861.140 | 16.909.190 | 16.875.240 | 17.469.793 | 18.727.562 |